As of 2026-09-17, the EV/EBITDA ratio of Twist Bioscience Corp (TWST) is -79.01. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Twist's latest enterprise value is 8,791.53 mil USD. Twist's TTM EBITDA according to its financial statements is -111.28 mil USD. Dividing these 2 quantities gives us the above Twist EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 12.4x - 16.3x | 14.8x |
| Forward P/E multiples | 13.8x - 16.5x | 14.8x |
| Fair Price | (22.74) - (27.17) | (24.56) |
| Upside | -115.9% - -119.0% | -117.2% |
| Date | EV/EBITDA |
| 2026-09-15 | -76.23 |
| 2026-09-14 | -74.35 |
| 2026-09-11 | -70.14 |
| 2026-09-10 | -69.93 |
| 2026-09-09 | -69.19 |
| 2026-09-08 | -70.61 |
| 2026-09-04 | -68.74 |
| 2026-09-03 | -70.97 |
| 2026-09-02 | -72.25 |
| 2026-09-01 | -72.85 |
| 2026-08-31 | -76.73 |
| 2026-08-28 | -78.06 |
| 2026-08-27 | -84.62 |
| 2026-08-26 | -82.92 |
| 2026-08-25 | -83.68 |
| 2026-08-24 | -77.74 |
| 2026-08-21 | -80.42 |
| 2026-08-20 | -75.23 |
| 2026-08-19 | -78.63 |
| 2026-08-18 | -63.91 |
| 2026-08-17 | -68.56 |
| 2026-08-14 | -65.30 |
| 2026-08-13 | -69.06 |
| 2026-08-12 | -69.01 |
| 2026-08-11 | -67.84 |
| 2026-08-10 | -68.83 |
| 2026-08-07 | -63.67 |
| 2026-08-06 | -59.99 |
| 2026-08-05 | -63.30 |
| 2026-08-04 | -54.59 |
| 2026-08-03 | -55.50 |
| 2026-07-31 | -50.18 |
| 2026-07-30 | -50.05 |
| 2026-07-29 | -46.77 |
| 2026-07-28 | -48.50 |
| 2026-07-27 | -47.37 |
| 2026-07-24 | -49.46 |
| 2026-07-23 | -50.67 |
| 2026-07-22 | -51.66 |
| 2026-07-21 | -52.59 |
| 2026-07-20 | -47.88 |
| 2026-07-17 | -51.46 |
| 2026-07-16 | -50.00 |
| 2026-07-15 | -50.77 |
| 2026-07-14 | -50.72 |
| 2026-07-13 | -49.50 |
| 2026-07-10 | -49.66 |
| 2026-07-09 | -51.36 |
| 2026-07-08 | -48.96 |
| 2026-07-07 | -49.88 |